Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Tifluadom, a κ-opioid agonist and cholecystokinin-A (CCK-A) receptor antagonist, was utilized as a model to prepare a series of 2-(aminomethyl)- and 3-(aminomethyl)-1,4-benzodiazepines.